Article info

Original research
Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study

Authors

  1. Correspondence to Professor Bart C Jacobs, Neurology and Immunology, Ee2289, Erasmus MC, Rotterdam, Netherlands; b.jacobs{at}erasmusmc.nl
View Full Text

Citation

Verboon C, Harbo T, Cornblath DR IGOS consortium, et al
Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study

Publication history

  • Received December 5, 2020
  • Revised April 6, 2021
  • Accepted April 11, 2021
  • First published June 8, 2021.
Online issue publication 
May 24, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.